Literature DB >> 10338481

Environmental modulation of oral treponeme virulence in a murine model.

L Kesavalu1, S C Holt, J L Ebersole.   

Abstract

This investigation examined the effects of environmental alteration on the virulence of the oral treponemes Treponema denticola and Treponema pectinovorum. The environmental effects were assessed by using a model of localized inflammatory abscesses in mice. In vitro growth of T. denticola and T. pectinovorum as a function of modification of the cysteine concentration significantly enhanced abscess formation and size. In contrast, growth of T. denticola or T. pectinovorum under iron-limiting conditions (e.g., dipyridyl chelation) had no effect on abscess induction in comparison to that when the strains were grown under normal iron conditions. In vivo modulation of the microenvironment at the focus of infection with Cytodex beads demonstrated that increasing the local inflammation had no effect on lesion induction or size. In vivo studies involved the determination of the effects of increased systemic iron availability (e.g., iron dextran or phenylhydrazine) on the induction, kinetics, and size of lesions. T. denticola induced significantly larger lesions in mice with iron pretreatment and demonstrated systemic manifestations of the infectious challenge and an accompanying spreading lesion with phenylhydrazine pretreatment (e.g., increases in circulating free hemoglobin). In contrast, T. pectinovorum virulence was minimally affected by this in vivo treatment to increase iron availability. T. denticola virulence, as evaluated by lesion size, was increased additively by in vivo iron availability, and cysteine modified growth of the microorganism. Additionally, galactosamine sensitized mice to a lethal outcome following infection with both T. denticola and T. pectinovorum, suggesting an endotoxin-like activity in these treponemes. These findings demonstrated the ability to modify the virulence capacity of T. denticola and T. pectinovorum by environmental conditions which can be evaluated by using in vivo murine models.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338481      PMCID: PMC96582          DOI: 10.1128/IAI.67.6.2783-2789.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Trypsin-like protease activity of Porphyromonas gingivalis as a potential virulence factor in a murine lesion model.

Authors:  L Kesavalu; S C Holt; J L Ebersole
Journal:  Microb Pathog       Date:  1996-01       Impact factor: 3.738

2.  Isolation and characterization of a hemin-binding cell envelope protein from Porphyromonas gingivalis.

Authors:  S J Kim; L Chu; S C Holt
Journal:  Microb Pathog       Date:  1996-07       Impact factor: 3.738

3.  The hemagglutinin genes hagB and hagC of Porphyromonas gingivalis are transcribed in vivo as shown by use of a new expression vector.

Authors:  S W Lee; J D Hillman; A Progulske-Fox
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Cystalysin, a 46-kilodalton cysteine desulfhydrase from Treponema denticola, with hemolytic and hemoxidative activities.

Authors:  L Chu; J L Ebersole; G P Kurzban; S C Holt
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Comparative virulence of periodontopathogens in a mouse abscess model.

Authors:  J L Ebersole; L Kesavalu; S L Schneider; R L Machen; S C Holt
Journal:  Oral Dis       Date:  1995-09       Impact factor: 3.511

6.  Bacterial infection as assessed by in vivo gene expression.

Authors:  D M Heithoff; C P Conner; P C Hanna; S M Julio; U Hentschel; M J Mahan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

7.  Virulence characteristics of oral treponemes in a murine model.

Authors:  L Kesavalu; S G Walker; S C Holt; R R Crawley; J L Ebersole
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

8.  Identification, isolation, and characterization of the 42-kilodalton major outer membrane protein (MompA) from Treponema pectinovorum ATCC 33768.

Authors:  S G Walker; J L Ebersole; S C Holt
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

9.  Involvement of lipopolysaccharide in the pathogenicity of Treponema hyodysenteriae.

Authors:  M E Nuessen; L A Joens; R D Glock
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  In vivo function of hemolysin in the nephropathogenicity of Escherichia coli.

Authors:  C Waalwijk; D M MacLaren; J de Graaff
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more
  6 in total

1.  Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages.

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

Review 2.  Microbiology and treatment of acute apical abscesses.

Authors:  José F Siqueira; Isabela N Rôças
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

3.  Lack of humoral immune protection against Treponema denticola virulence in a murine model.

Authors:  L Kesavalu; S C Holt; J L Ebersole
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Biological characterization of lipopolysaccharide from Treponema pectinovorum.

Authors:  Lakshmyya Kesavalu; Clinton W Falk; Kenneth J Davis; Michelle J Steffen; Xiaoping Xu; Stanley C Holt; Jeffrey L Ebersole
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  Glutathione catabolism by Treponema denticola impacts its pathogenic potential.

Authors:  Lianrui Chu; Yimin Wu; Xiaoping Xu; Linda Phillips; David Kolodrubetz
Journal:  Anaerobe       Date:  2020-02-07       Impact factor: 3.331

6.  Clinical and pharmacological management of endodontic flare-up.

Authors:  Harikaran Jayakodi; Sivakumar Kailasam; Karthick Kumaravadivel; Boopathi Thangavelu; Sabeena Mathew
Journal:  J Pharm Bioallied Sci       Date:  2012-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.